Trials / Conditions / Chronic Myelogenous Leukemia in Chronic Phase
Chronic Myelogenous Leukemia in Chronic Phase
4 registered clinical trials studyying Chronic Myelogenous Leukemia in Chronic Phase — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC NCT06684964 | Novartis Pharmaceuticals | — |
| Completed | CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib NCT01227577 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response NCT01043874 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leuk NCT00237120 | Novartis | Phase 3 |